Document Detail

In vivo testing of the therapeutic efficacy of chloroquine on falciparum malaria infections in Chirundu, Mashonaland West, Zimbabwe.
MedLine Citation:
PMID:  10101434     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To detect the level of the in vivo chloroquine efficacy in falciparum malaria infections, in order to assess the need for change in the management and treatment of uncomplicated malaria. DESIGN: Prospective descriptive study. SETTING: Chirundu Rural Clinic, Mashonaland West Province. SUBJECTS: 63 patients confirmed by a positive blood slide for P. falciparum who attended Chirundu clinic, who were eligible for the study and, who also agreed to participate. MAIN OUTCOME MEASURE(S): Frequency of treatment success, early treatment failure and late treatment failure in uncomplicated patients treated with chloroquine. RESULTS: Out of 63 cases enrolled and completely followed up, chloroquine treatment was effective in 54 cases (85.7%) and was not effective in nine cases (14.3%). All treatment failures were successfully treated with sulphadoxine + pyrimethamine (Fansidar) or quinine following the approved guidelines. CONCLUSIONS: Chloroquine remains highly effective in the treatment of malaria due to P. falciparum in the Zambezi Valley of Hurungwe district and therefore, has to remain the first line drug. Likewise, guidelines for the use of sulphadoxine + pyrimethamine (Fansidar) or quinine as second line drugs, are adequate to the local situation. Health workers directly supervised the patients when they were swallowing the tablets during the whole course, and this without doubt, indirectly increased the efficacy of chloroquine. It is vital to confirm the malaria diagnosis on the spot appointing microscopists or distributing a limited stock of Parasight-F test.
P Barduagni; U Schwartz; W Nyamayaro; T L Chauke
Related Documents :
9790434 - Characteristics of plasmodium falciparum parasites that survive the lengthy dry season ...
11665724 - A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer s...
9597244 - Evaluation of an intensive intermittent-induction regimen and duration of short-course ...
2028754 - Medical manpower requirements following penetrating keratoplasty for herpes simplex ker...
7972484 - The efficacy of breast augmentation: breast size increase, patient satisfaction, and ps...
10361334 - Vascular surgical society of great britain and ireland: randomized controlled trial of ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Central African journal of medicine     Volume:  44     ISSN:  0008-9176     ISO Abbreviation:  Cent Afr J Med     Publication Date:  1998 Oct 
Date Detail:
Created Date:  1999-04-15     Completed Date:  1999-04-15     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372566     Medline TA:  Cent Afr J Med     Country:  ZIMBABWE    
Other Details:
Languages:  eng     Pagination:  251-4     Citation Subset:  IM    
Mashonaland West Ministry of Health and Child Welfare, Zimbabwe/Italian Cooperation.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antimalarials / blood,  therapeutic use*
Chloroquine / blood,  therapeutic use*
Drug Resistance
Malaria, Falciparum / blood,  drug therapy*
Prospective Studies
Treatment Outcome
Reg. No./Substance:
0/Antimalarials; 54-05-7/Chloroquine
Comment In:
Cent Afr J Med. 1999 Feb;45(2):48   [PMID:  10444902 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nutritional status of HIV-1 seropositive patients in the Free State Province of South Africa--labora...
Next Document:  Relationship between estimated body fat and some respiratory function indices.